PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
Affiliation
Institute of Cancer Sciences, University of Manchester; Department of Academic Surgery, University Hospital of South ManchesterIssue Date
2016-04
Metadata
Show full item recordAbstract
Circulating tumour cells (CTCs) are a marker of poor prognosis and are associated with increased risk of venous thromboembolism in metastatic breast cancer.Citation
PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer. 2016, 140 Suppl 1:S188 Thromb ResJournal
Thrombosis ResearchDOI
10.1016/S0049-3848(16)30164-5PubMed ID
27161721Type
ArticleLanguage
enISSN
1879-2472ae974a485f413a2113503eed53cd6c53
10.1016/S0049-3848(16)30164-5
Scopus Count
Collections
Related articles
- Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
- Authors: Kirwan CC, Descamps T, Castle J
- Issue date: 2020 Jun
- Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
- Authors: Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM
- Issue date: 2015 Mar
- Neutrophil Extracellular Traps Enhance Procoagulant Activity and Predict Poor Prognosis in Patients With Metastatic Breast Cancer.
- Authors: Gong Y, Chen B, Tan Q, Wei W
- Issue date: 2025
- Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
- Authors: Shaker H, Bundred NJ, Landberg G, Pritchard SA, Albadry H, Nicholson SL, Harries LJ, Heah JYE, Castle J, Kirwan CC
- Issue date: 2020 Mar
- Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
- Authors: Fan BE, Ramanathan K, Sum CLL, Christopher D, Chan SSW, Lim GH, Bok CF, Wong SW, Lye DC, Young BE, Lim JY, Lee RM, Lim SP, Tan HT, Ang MK, Lau SL, Kuperan P, Ong KH, Chia YW
- Issue date: 2022 Apr